FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1196.4469

Resources that use this resource

No resources found

Resources that this resource uses

Narrative

No narrative content found in resource

Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1196.4469",
  "meta": {
    "versionId": "10",
    "lastUpdated": "2024-07-29T08:54:37.000-04:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "CDC DHP TEB Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-05-15"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2024-05-15"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4469",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1196.4469"
    }
  ],
  "version": "20240515",
  "name": "CabotegravirInjectableProducts",
  "title": "Cabotegravir Injectable Products",
  "status": "active",
  "date": "2024-05-15T01:01:25-04:00",
  "publisher": "CDC DHP TEB Steward",
  "description": "Under Cooperative Agreement number 6-NU38OT000316, funded by the CDC Division of Sexually Transmitted Disease Prevention and the Division of HIV Prevention, the Public Health Informatics Institute coordinated a project to test the feasibility, usability and acceptance of a CDS solution aimed at increasing adherence to public health guidelines for treating gonorrhea, encouraging human immunodeficiency virus screening and raising awareness of pre-exposure prophylaxis prescriptions in clinical settings. See https://phii.org/sti-connect-cds/ for full information.  This value set was created to support that work and could be used to inform the development of a similar solution in a clinical environment.  It is important to note that the CDS solution incorporated portions of public health guidelines for GC treatment, HIV screening and PrEP education and does not reflect a full implementation of the guidelines.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: GPCK & BPCKs were added manually by finding codes in RxNav),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "2475408",
            "display": "cabotegravir Injectable Product"
          },
          {
            "code": "2475415",
            "display": "{1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack"
          },
          {
            "code": "2475416",
            "display": "{1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 600 MG / 900 MG]"
          },
          {
            "code": "2475417",
            "display": "{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack"
          },
          {
            "code": "2475418",
            "display": "{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 400 MG / 600 MG]"
          },
          {
            "code": "2588046",
            "display": "Apretude Injectable Product"
          },
          {
            "code": "2588076",
            "display": "cabotegravir Injection"
          },
          {
            "code": "2588077",
            "display": "3 ML cabotegravir 200 MG/ML Injection"
          },
          {
            "code": "2588078",
            "display": "cabotegravir 200 MG/ML Injection"
          },
          {
            "code": "2588079",
            "display": "cabotegravir Injection [Apretude]"
          },
          {
            "code": "2588080",
            "display": "3 ML cabotegravir 200 MG/ML Injection [Apretude]"
          },
          {
            "code": "2588081",
            "display": "cabotegravir 200 MG/ML Injection [Apretude]"
          },
          {
            "code": "2594978",
            "display": "2 ML cabotegravir 200 MG/ML Injection"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:42c03212-65fe-4256-a1ee-d76cb6edf6e7",
    "timestamp": "2025-05-23T19:13:44-04:00",
    "total": 11,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2475408",
        "display": "cabotegravir Injectable Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2475415",
        "display": "{1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2475416",
        "display": "{1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 600 MG / 900 MG]"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2475417",
        "display": "{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2475418",
        "display": "{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 400 MG / 600 MG]"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2588046",
        "display": "Apretude Injectable Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2588076",
        "display": "cabotegravir Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2588077",
        "display": "3 ML cabotegravir 200 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2588079",
        "display": "cabotegravir Injection [Apretude]"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2588080",
        "display": "3 ML cabotegravir 200 MG/ML Injection [Apretude]"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2594978",
        "display": "2 ML cabotegravir 200 MG/ML Injection"
      }
    ]
  }
}